Denis Larsimont

基本信息

Career Trajectory

Bio

Larsimont D is currently working in the Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. He has published numerous research papers and articles in reputed journals and has various other achievements in the related studies. He has extended his valuable service towards the scientific community with his extensive research work.

Research Interest
Breast cancer, Natrium-iodide symporter, Endocrine receptor.

Research Interests

Papers共 539 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Supplementary Figure S1 from Integrating Molecular Imaging and Transcriptomic Profiling in Advanced HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine: an Analysis of the ZEPHIR Clinical Trial

Mattia Rediti,Danai Fimereli,Magdalena Mileva,Zéna Wimana,David Venet,Patrick Flamen,Thomas Guiot,Elisabeth G.E. de Vries,Carolien P. Schröder, Catharina Willemien Menke-van der Houven van Oordt,Marion Maetens,Samira Majjaj,Denis Larsimont,Françoise Rothé,Christos Sotiriou,Géraldine Gebhart

crossref（2025）

Cited0Views0Bibtex

Supplementary Table S2 from Integrating Molecular Imaging and Transcriptomic Profiling in Advanced HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine: an Analysis of the ZEPHIR Clinical Trial

crossref（2025）

Cited0Views0Bibtex

Supplementary Figure S4 from Integrating Molecular Imaging and Transcriptomic Profiling in Advanced HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine: an Analysis of the ZEPHIR Clinical Trial

crossref（2025）

Cited0Views0Bibtex

Supplementary Table S7 from Integrating Molecular Imaging and Transcriptomic Profiling in Advanced HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine: an Analysis of the ZEPHIR Clinical Trial

crossref（2025）

Cited0Views0Bibtex

Impact of Margin Distance on Recurrence and Survival Following Breast-Conserving Surgery after Neoadjuvant Systemic Therapy

C Florin Pop, Clémence Ortega, Mathilde Lecomte, Paulus Kristanto, Chirine Khaled, Filip De Neubourg,Antoine Desmet,Evandro De Azambuja,Denis Larsimont, Isabelle Veys

NPJ breast cancer（2025）

Cited0Views0WOSBibtex

Supplementary Figure S3 from Integrating Molecular Imaging and Transcriptomic Profiling in Advanced HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine: an Analysis of the ZEPHIR Clinical Trial

crossref（2025）

Cited0Views0Bibtex

Supplementary Figure S5 from Integrating Molecular Imaging and Transcriptomic Profiling in Advanced HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine: an Analysis of the ZEPHIR Clinical Trial

crossref（2025）

Cited0Views0Bibtex

Supplementary Table S9 from Integrating Molecular Imaging and Transcriptomic Profiling in Advanced HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine: an Analysis of the ZEPHIR Clinical Trial

crossref（2025）

Cited0Views0Bibtex

Supplementary Figure S6 from Integrating Molecular Imaging and Transcriptomic Profiling in Advanced HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine: an Analysis of the ZEPHIR Clinical Trial

crossref（2025）

Cited0Views0Bibtex

Supplementary Figure S2 from Integrating Molecular Imaging and Transcriptomic Profiling in Advanced HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine: an Analysis of the ZEPHIR Clinical Trial

crossref（2025）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn

Professor

Papers共 539 篇Author StatisticsCo-AuthorSimilar Experts